In order to improve the overall clinical performance of the LC-SPIK test, LC-SPIK was combined with other HCC biomarkers, such as AFP and PIVKA-II (also known as DCP), other proteomic biomarker for HCC with relatively strong support in the clinical literature [11,72,73]. Here, ACE is linked to hepatocellular carcinoma.